The Role of Thioredoxin System in Cancer Immunotherapy
Author Information
Author(s): Sun Lin, Yu Anni, Yang Yang, Wang Zhiruo, Wang Wenqian, Luo Lan
Primary Institution: State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University
Hypothesis
The thioredoxin system is integral to tumor immunity and may serve as a predictor for immunotherapy response.
Conclusion
The Trx system is a good predictor of both survival and the efficacy of immunotherapy, as well as clinical prognosis.
Supporting Evidence
- An abnormal expression of the Trx system is observed in cancer cells.
- Interference with the Trx system significantly inhibits tumor cell growth.
- The Trx system showed a relatively consistent aberrant expression in pan-cancer.
- The abnormal expression of the thioredoxin system was positively correlated with immune infiltration.
- The Trx system was associated with immune response to immunotherapy.
Takeaway
The thioredoxin system helps cancer cells grow and can affect how well immunotherapy works, making it an important target for treatment.
Methodology
The study analyzed Trx system proteins using various databases and methods including Western blotting, MTT assays, and survival analysis with Kaplan-Meier plots.
Limitations
Further investigation is necessary to determine whether the Trx system can accurately predict immunotherapy sensitivity and combination therapies.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website